Genomic medicine offers significant promise for more effective prevention and treatment for those at higher risk of diseases such as cancer.
As health care systems launch new genetic screening programs, understanding the patient’s experience is vital to shaping strategies that overcome barriers to participation and follow-up care.
Research conducted through aProvidence early detection and prevention pilot program highlighted a need for clear communication from trusted health care providers about the benefits and next steps, and the importance of providing information about treatment options and follow-up care.
